Abiomed (ABMD) Updates on Impella 2.5 PMA Filing; Doesn't See Need for Additional Requirement
Tweet Send to a Friend
Abiomed (NASDAQ: ABMD) disclosed the following on Monday:Item 7.01 Regulation FD Disclosure.Today, ABIOMED, Inc. (“the Company”) announces that the Company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
